REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $336,468 | +61.8% | 3,300 | -60.1% | 0.22% | +61.7% |
| Q3 2022 | $208,000 | -17.1% | 8,265 | 0.0% | 0.13% | -22.7% |
| Q2 2022 | $251,000 | -7.4% | 8,265 | 0.0% | 0.17% | +33.3% |
| Q1 2022 | $271,000 | +24.3% | 8,265 | 0.0% | 0.13% | +98.5% |
| Q4 2021 | $218,000 | -73.8% | 8,265 | 0.0% | 0.06% | -75.6% |
| Q3 2021 | $832,000 | -28.9% | 8,265 | 0.0% | 0.27% | -26.9% |
| Q2 2021 | $1,170,000 | – | 8,265 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |